Skip to main content
Medical Affairs
Our Company
Who We Are
Leadership
Focus Areas
Overview
Oncology
Immunology & Inflammation
Neurology
Pipeline
Ongoing Clinical Trials
Presentations & Publications
Patients & Care Partners
Expanded Access
Healthcare Professionals (Coming soon!)
Our Medicines
Join Us
Our Culture
Open Positions
News
Ono Pharma
ONO-2020
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease (NCT06881836)
Neurology
Disease/Condition: Alzheimer’s Disease
Back to top
